People who take a commonly prescribed blood pressure medication are being warned about a product recall on a particular batch of the drugs.
Crescent Pharma Limited is recalling ramipril 2.5mg capsules due to a packaging error, which may mean some cartons contain blister strips of a higher dose. The medicine is used for the treatment of high blood pressure, kidney disease and heart failure.
The UK’s medicines watchdog, the Medicines and Healthcare products Regulatory Agency (MHRA), is alerting anyone who takes the pills to the recall, urging them to check the batch number of their medication.
Click here to get the biggest stories straight to your inbox in our Daily Newsletter
Taking a higher dose of ramipril than required may results in symptoms such as fainting, fatigue or altered kidney function, the MHRA warned.
Dr Alison Cave, MHRA chief safety officer, said: “If you take Crescent Pharma Limited Ramipril 2.5mg capsules, check the packaging for batch number GR155023. The batch number and expiry date information can be found on the outer carton. If you have received this batch, check that the medication strength on the carton matches the blister strips inside.”
She explained that some 2.5mg cartons may contain blister strips that are labelled as Ramipril 10mg capsules. If that is the case, she urged people not to take the medicine and instead contact their dispensing pharmacy. If the carton contains blister strips that are correctly labelled as Crescent Pharma Limited Ramipril 2.5mg capsules, there is no need to take any further action and you can continue to take your medicine as usual, she added.
Ramipril is commonly prescribed in the UK to people with high blood pressure and heart problems -Credit:MHRA
Dr Cave continued: “If you have an affected pack or previously received this batch and you believe you have taken any Ramipril 10mg capsules that were included in error and are currently experiencing any side effects, please seek medical advice.
“Signs and symptoms may include feeling lightheaded, fainting or being fatigued, or altered kidney function and may be more serious for vulnerable patients. Any possible impact of taking a higher dose of ramipril should be assessed by a healthcare professional to determine whether any examination or tests are needed.”
The MHRA said the recall comes after a healthcare professional found that a sealed carton of Crescent Pharma Limited Ramipril 2.5mg capsules contained two blister strips of 10mg capsules. Both product batches were manufactured at the same site, and the error appears to have occurred during packaging of the cartons, the watchdog said.
The MHRA said it has advised pharmacies and healthcare professionals to stop supplying the impacted batch and return all remaining stock to their suppliers.
Details of the affected batch
Manufacturer: Crescent Pharma Limited
Batch number: GR155023
Expiry date: 08/2027
Pack size: 28 tablets
Date first distributed: 16 Jan 2026